BIOC.EGX Glaxo Smith Kline

290.70 EGP
Close of Oct 29, 2026
58.03 550.00
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is BIOC.EGX undervalued?

Graham number

The Graham number of Glaxo Smith Kline cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Glaxo Smith Kline fundamental analysis

No fundamental analysis for Glaxo Smith Kline yet.

Glaxo Smith Kline stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.